http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008050372-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-51 |
| filingDate | 2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a7ec5e9e927a69b2cdc1a8baa442ecc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a708851a39d9730f9bc62d1c7030c784 |
| publicationDate | 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008050372-A |
| titleOfInvention | Intervertebral hernia treatment |
| abstract | [PROBLEMS] To provide a pharmaceutical composition and a drug that can be used for the treatment of a type of intervertebral disc herniation in which the nucleus pulposus exists outside the spinal dura, such as spinal epidural migration type disc herniation and transligament prolapse disc herniation. To do. An epidural migration type containing a glycosaminoglycan degrading enzyme, preferably chondroitinase, more preferably chondroitinase ABC, in an amount effective for dissolving the nucleus pulposus existing in the epidural region. A pharmaceutical composition for the treatment of a type of intervertebral disc herniation in which the nucleus pulposus is located outside the spinal dura, such as an intervertebral disc herniation or transligament prolapse disc herniation. [Selection] Figure 1 |
| priorityDate | 1997-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.